Table 4.

Multivariate analyses of CCL5, ER-α, ER-β, PR, and ErbB2 expression in breast cancer patients using Cox proportional hazard models

PHR95% limits
Stage I
    CCL50.7610.8720.362, 2.101
    ER-α0.9071.0550.426, 2.614
    ER-β0.7841.1520.419, 3.17
    PR0.9190.9540.388, 2.346
    ErbB20.0632.2760.957, 5.417
Stage II
    CCL50.0052.2561.282, 3.969
    ER-α0.0490.5370.289, 0.996
    ER-β0.4430.7850.423, 1.456
    PR0.5500.8270.443, 1.543
    ErbB20.9680.9870.518, 1.879